IGC Pharma (IGC) Gross Margin (2010 - 2025)
IGC Pharma (IGC) posted quarterly Gross Margin of 51.83% for Q3 2025, up 377.0% year-over-year from 10.87% in Q3 2024, and up 10.4% quarter-over-quarter from 46.95% in Q2 2025.
IGC Pharma (IGC) Gross Margin (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Gross Margin for 16 consecutive years, with 51.83% the latest figure, recorded in Q3 2025.
- In Q3 2025, Gross Margin rose 377.0% year-over-year to 51.83%; the TTM figure through Sep 2025 stood at 46.2% (down 1001.0% YoY), while the FY2026 annual figure was 17.35%, down 3135.0% from the prior year.
- Gross Margin climbed to 51.83% in Q3 2025 per IGC's latest filing, from 46.95% in the prior quarter.
- Across five years, Gross Margin topped out at 67.86% in Q3 2021 and bottomed at 30.72% in Q4 2022.
- Historically, Gross Margin has averaged 50.51% across 5 years, with a median of 48.06% in 2024.
- Annual changes were most pronounced in 2021 — Gross Margin jumped 4706 bps — and 2024, when it slumped 2473 bps.
- IGC Pharma's Gross Margin stood at 43.66% in 2021, then decreased by 30 bps to 30.72% in 2022, then soared by 112 bps to 65.2% in 2023, then plunged by 38 bps to 40.47% in 2024, then rose by 28 bps to 51.83% in 2025.
- Business Quant data shows IGC's Gross Margin at 51.83% in Q3 2025, 46.95% in Q2 2025, and 46.67% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 76.90% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 84.20% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 63.27% |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 51.83% |
| Jun 30, 2025 | 46.95% |
| Mar 31, 2025 | 46.67% |
| Dec 31, 2024 | 40.47% |
| Sep 30, 2024 | 48.06% |
| Jun 30, 2024 | 59.93% |
| Mar 31, 2024 | 57.97% |
| Dec 31, 2023 | 65.20% |
| Sep 30, 2023 | 59.79% |
| Jun 30, 2023 | 45.95% |
| Mar 31, 2023 | 37.95% |
| Dec 31, 2022 | 30.72% |
| Sep 30, 2022 | 66.83% |
| Jun 30, 2022 | 66.98% |
| Mar 31, 2022 | 55.74% |
| Dec 31, 2021 | 43.66% |
| Sep 30, 2021 | 67.86% |
| Jun 30, 2021 | 33.77% |
| Mar 31, 2021 | 33.33% |
| Dec 31, 2020 | 12.96% |